Join Marla Littlejohn and Dr. Gigi for a compelling conversation on dermatology, enriched by Marla's personal experience with psoriasis.

What to look for: Most studies on OTC niacinamide used formulas with 2 to 5 percent concentrations, and research shows that ...

I TURNED 45 last week and it got me reflecting on age and health. I saw a social media post saying scientists had found that we age dramatically in two bursts, once at 44, then again at 60 – and ...

Turmeric, a traditional Indian spice, offers beauty benefits, while curcumin, its active compound, provides more potent ...

Icotrokinra is efficacious and safe for treating moderate to severe plaque psoriasis among adolescents and adults when compared with placebo.

Psoriasis shows on the skin, but it's a disease which goes a lot deeper and is linked to serious health problems. In recent years, newer targeted drugs are making a difference.

New results from a subgroup analysis of the ICONIC-LEAD study showed icotrokinra was effective and safe for the treatment of moderate to severe plaque psoriasis in adolescents, according to a press ...

Deucravacitinib has been observed as a safe and efficacious treatment for adults with moderate to severe plaque psoriasis for up to 4 years.

No association was observed between serious infection risk and Janus kinase inhibitor use in patients with immune-mediated inflammatory skin disease.

Managing psoriasis is more than going to your doctor's appointments. Learn from experts on how to improve your self-care.

An expert discusses how the VISIBLE study examined comorbidity burden in moderate to severe psoriasis across all skin tones, addressing disparities in research. It aimed to highlight unmet needs and ...